That's how I read it.
"The study recruited 30 patients with newly diagnosed glioblastoma and
unmethylated MGMT promotor status, a genetic profile which confers primary
resistance to temozolomide, the only existing FDA-approved drug treatment for first
line treatment."
- Forums
- ASX - By Stock
- Ann: Kazia releases final data from P2 paxalisib trial
That's how I read it."The study recruited 30 patients with newly...
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online